The first mini seminar addresses controversial, but commonly encountered, issues in the management of benign and malignant parotid disease. We will review the data regarding (1) capsular dissection for pleomorphic adenoma and other benign salivary tumors; (2) superficial versus total parotidectomy for both primary malignancy and cutaneous metastases; (3) indications for neck dissection with primary parotid malignancy; (4) Management of the facial nerve in the setting of malignancy and (5) Complication rates and management. This session will allow for audience interaction and appeal to general otolaryngologists, academicians, and trainees, in addition to the head and neck oncological surgeon. This two-hour panel presentation will cover the topics above using a combination of didactics, audience response queries, and case-based examples. The second mini seminar addresses controversial, but commonly encountered, issues in the management of benign and malignant parotid disease. We will review the data regarding (1) capsular dissection for pleomorphic adenoma and other benign salivary tumors; (2) superficial versus total parotidectomy for both primary malignancy and cutaneous metastases; (3) indications for neck dissection with primary parotid malignancy; (4) Management of the facial nerve in the setting of malignancy and (5) Complication rates and management. This session will allow for audience interaction and appeal to general otolaryngologists, academicians, and trainees, in addition to the head and neck oncological surgeon. This two-hour panel presentation will cover the topics above using a combination of didactics, audience response queries, and case-based examples.